BRXBX
Price
$13.69
Change
-$0.16 (-1.16%)
Updated
Nov 8 closing price
VGTSX
Price
$19.97
Change
-$0.27 (-1.33%)
Updated
Nov 8 closing price
Ad is loading...

BRXBX vs VGTSX

Header iconBRXBX vs VGTSX Comparison
Open Charts BRXBX vs VGTSXBanner chart's image
MFS Blended Research Intl Eq B
Price$13.69
Change-$0.16 (-1.16%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$19.97
Change-$0.27 (-1.33%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
BRXBX vs VGTSX Comparison Chart
Loading...
VS
BRXBX vs. VGTSX commentary
Nov 10, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRXBX is a StrongSell and VGTSX is a StrongSell.

FUNDAMENTALS
Fundamentals
VGTSX has more cash in the bank: 442B vs. BRXBX (723M). VGTSX pays higher dividends than BRXBX: VGTSX (3.20) vs BRXBX (1.67). BRXBX was incepted earlier than VGTSX: BRXBX (9 years) vs VGTSX (29 years). BRXBX is a more actively managed with annual turnover of: 56.00 vs. VGTSX (4.00). VGTSX has a lower initial minimum investment than BRXBX: VGTSX (0) vs BRXBX (1000). BRXBX annual gain was more profitable for investors over the last year : 25.34 vs. VGTSX (17.61). BRXBX return over 5 years is better than : 30.65 vs. VGTSX (19.10).
BRXBXVGTSXBRXBX / VGTSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years29 years-
Gain YTD14.0837.674184%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets723M442B0%
Annual Yield % from dividends1.673.2052%
Returns for 1 year25.3417.61144%
Returns for 3 years3.46-3.15-110%
Returns for 5 years30.6519.10160%
Returns for 10 yearsN/A33.86-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WTBA23.930.44
+1.87%
West Bancorporation
WINA410.464.48
+1.10%
Winmark Corp
BMI223.470.22
+0.10%
Badger Meter
CTVA58.33-0.31
-0.53%
Corteva
MRKR4.14-0.15
-3.50%
Marker Therapeutics